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Background: Mental health services in England are smoke-free by law and expected to provide comprehensive
support to patients who smoke. Although clinicians’ knowledge in this area is reported to be limited, research
exploring the issue in Child and Adolescent Mental Health Services (CAMHS) is lacking. This study aimed to investigate
the knowledge, attitudes, and practice of clinicians working within specialist and highly specialist Child and Adolescent
Mental Health Services (CAMHS) relating to tobacco dependence, its treatment and its relation to mental disorder.
Methods: A cross-sectional survey of clinicians working across all CAMHS teams of a large UK National Health
Service mental health Trust.
Results: Sixty clinicians (50% response rate) completed the survey. Less than half (48.3%) believed that addressing
smoking was part of their responsibility, and half (50%) asserted confidence in supporting patients in a cessation
attempt. Misconceptions relating to smoking were present across all staff groups: e.g. only 40% of respondents were
aware of potential interactions between smoking and antipsychotic medications, although psychiatrists were more
knowledgeable than non-medical clinicians (91.6% vs 27.1%; OR 3.4, p < .001). Self-reported attendance at smoking-
related training was significantly associated with more proactive clinical practice.
Conclusions: There is a need to improve clinicians’ knowledge, capacity and confidence in effectively identifying,
motivating, supporting and treating young smokers in the context of treatment for mental disorders.
Keywords: Smoking, Mental illness, Tobacco, Addiction, Mental health servicesBackground
The links between smoking and mental disorder are com-
plex and strong, with smoking prevalence, tobacco depend-
ence, and smoking-related disease and mortality being
disproportionately high among people with mental disor-
ders compared to the general population [1,2] causing and
exacerbating existing health inequalities in this vulnerable
group [3]. The strength of the association between tobacco
dependence and mental disorders is determined by a
multitude of factors that include neurobiological, genetic
and, importantly, psychosocial and cultural phenomena.* Correspondence: Lisa.Huddlestone@nottingham.ac.uk
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unless otherwise stated.Recognising these links gains particular importance in the
context of smoke-free policies that were introduced in
English National Health Service (NHS) mental health
Trusts, which provide specialist treatment and care for
people with mental disorders. Smoking cessation or ab-
stinence, for example in the context of admission to an in-
patient unit, can impact on drug metabolism and require
monitoring to prevent potential drug toxicity [4]. While
research to date has focussed on exploring and addressing
smoking in adults with mental disorders, attention has re-
cently been drawn to the importance of this topic in child
and adolescent mental health services, both from a treat-
ment and a prevention perspective [3].
There is evidence to highlight a strong association be-
tween mental disorders and smoking in adolescence [5,6],l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ADHD, or conduct disorder being more likely to smoke
than their peers without these disorders [7,8]. In addition,
the prevalence of smoking among individuals with first
episode psychosis is six times higher than in matched aged
and gender controls [5]. With most smoking behaviour
initiated prior to adulthood [6], an increased likelihood of
becoming heavier and more persistent smokers, and the
contribution of tobacco dependence to increased health
inequality [2,9], the Royal College of Physicians and the
Royal College of Psychiatrists in the UK recommend tar-
geted approaches for children and young people with
emotional and behavioural disorders and highlight an ur-
gent need for the identification of young smokers and the
co-ordinated assessment and treatment of tobacco de-
pendence in the context of treatment for emerging mental
disorders [3].
Recently, the UK government committed to strategies
aiming to improve physical health outcomes among
people with mental disorders [10]. In this context, the
introduction of smoke- free policies within mental health
trusts has been described as an avenue towards promoting
a smoke- free lifestyle [11]. Recent guidance from the Na-
tional Institute for Health and Clinical Excellence [12]
stipulates the provision of comprehensive, evidence-based
treatment and support for patients with mental illness
who smoke. Despite this and evidence that smokers with
mental illness are similarly as motivated to quit as smokers
without mental illness, and can successfully do so when
supported appropriately [13], challenges in addressing
smoking in mental health settings have been highlighted.
Research within adult mental health services revealed
that clinical staff are integral to the implementation of
smoke-free practices, yet staff attitudes were found to be
ambivalent [14-16]. Evidence suggests that that clinicians
based in adult mental health inpatient settings may not
be sufficiently equipped to support patients in addressing
their smoking behaviour effectively, often reporting a
lack of awareness and knowledge of tobacco dependence,
its treatment, and interaction with mental disorders
[15,17,18], including the fact that quitting smoking has
been shown to improve symptoms of mental illness (ra-
ther than exacerbate them, as commonly assumed) [19].
To our knowledge, no research has been carried out to
explore issues relating to smoking and treating smoking
in the context of child and adolescent mental health ser-
vices specifically. Responding to calls to address this
knowledge gap, this study investigates mental health
professionals’ knowledge and attitudes relating to smok-
ing, its treatment, and its links with mental disorder, as
well as clinical practice of addressing tobacco depend-
ence among children and young people accessing Child
and Adolescent Mental Health Services (CAMHS) in
the UK.Methods
Settings and participants
All clinicians working within a specialist CAMHS in one
of the UK’s largest National Health Service (NHS) men-
tal health trusts were invited to participate the paper
based survey. In England, treatment and care for chil-
dren and adolescents (up to 18 years of age) who have
significant mental health problems or disorders is orga-
nised through a tier system, according to severity of
symptoms and conditions from Tier 1 (primary care) to
Tiers 3 and 4 (specialist and highly specialist (mainly in-
patient) support). The teams included in the survey
comprised several tier 3 “Looked After Children” i.e.
children under the care of social care services; Neurode-
velopmental Psychiatry; Paediatric Liaison; Substance
Misuse and Early Intervention Psychosis; Specialist
Community CAMHS; and Self-harm) and tier 4 (Adoles-
cent In-patient and Intensive Intervention) teams. The
names of all clinical staff involved in patient care were
obtained from team leaders and personalised invitations
including questionnaires posted to all staff. Survey com-
pletion was not incentivised, however responses were
encouraged by advertising in staff areas, email cascade
from the service managers, and in team meetings. A
follow-up letter and questionnaire were sent to all non-
respondents after four weeks. Ethical approval for the
study was obtained from The University of Nottingham
School of Medicine Ethics Committee and permission to
conduct the research was given by Nottinghamshire
Healthcare NHS Trust.
Study instrument
Based on the instrument used in a previous study [15], a
questionnaire was designed to explore mental health pro-
fessionals’ knowledge, attitudes, and clinical practice re-
lated to tobacco dependence, its treatment and links with
mental disorders Additional file 1. Twenty seven items
relating to clinician characteristics, including training
participation; clinician knowledge; the interplay between
tobacco smoke and mental disorder; carcinogenic proper-
ties of tobacco smoke; symptoms of nicotine withdrawal;
and clinician attitudes and practice were assessed by
closed and multiple choice questions, as well as Likert
scales. Clinician knowledge was assessed by asking respon-
dents to give estimates of smoking prevalence within both
the general and mental health populations and clinicians
were asked to indicate their response of “true”, “false” or
don’t know” to questions relating to the carcinogenic
properties of tobacco smoke and the interplay between
tobacco dependence and mental disorders. In the assess-
ment of respondents’ knowledge of the symptoms of
nicotine withdrawal, participants were asked to select the
correct symptoms from a list of twenty possible symp-
toms. Options were based upon the Diagnostic and
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(DSM-IV) diagnostic criteria for nicotine withdrawal
(dysphoric or depressed mood; insomnia; irritability;
frustration or anger; anxiety; difficulty in concentrating;
restlessness; and decreased heart rate) and these were
supplemented by seven additional symptoms of nico-
tine withdrawal (decreased tremor, cold symptoms,
mouth ulcers, decreased caffeine metabolism, constipa-
tion, light headedness and weight gain) that have been
identified in smoking research [20]. Five false options
(e.g. headache) were included. Clinicians’ attitudes and
practices in terms of addressing smoking with their pa-
tients were assessed by asking respondents to rate their
agreement with a series of statements on a 5-point
Likert scale (strongly agree to strongly disagree); re-
spondents were then asked to rate on a 10-point nu-
merical scale how important they felt it was to address
patients’ smoking in the context of treatment for men-
tal disorders, and how confident they felt in supporting
patients to effectively quit smoking (scales ranged from
1 = not at all important/confident to 10 = extremely im-
portant/confident).
Procedures
Survey responses were coded, entered, and analysed
using IBM SPSS (version 21). Staff groups were cate-
gorised for analysis into medical (psychiatric consultants
and junior doctors) and non-medical staff (nurses, psy-
chologists, systemic therapists, other therapists and
other health professionals). Where significant differences
were detected between these groups, medical and non-
medical staff groups were sub-divided for more detailed
analysis (doctors, nurses, psychologists, and other thera-
pists). Other a priori categories for analysis were based
on reported smoking status (smokers vs. non-smokers/
ex-smokers), age (under 49 years and over 49 years, as
per median age), gender, whether respondents worked in
a community setting or if they were ward or hospital
based (adolescent in-patient team and paediatric liaison
team), and reported training attendance relating to
smoking in the past two years. The responses to the 5-
point Likert scale items were dichotomised for analysis,
with strong agreement and agreement forming one cat-
egory and undecided, disagreement and strong disagree-
ment forming the other. To assess levels of participants’
knowledge in relation to tobacco dependence, its treat-
ment and its relation with mental illness, responses true,
false, and “don’t know” were coded into two categories:
correct and incorrect categories, with the answer “don’t
know” being coded as incorrect. Performance relating to
knowledge of the symptoms of nicotine withdrawal were
ranked to obtain an overall measure of performance by
aggregating points as follows: +1 (correctly identified
symptoms), 0 (correct symptoms not identified) and −1(incorrectly identified symptoms). The overall percent-
age of correct answers was also calculated.
Data analysis
Descriptive analysis was performed to obtain means, me-
dians, standard deviations, and proportions. Univariate
analysis of categorical and continuous data was performed
using Chi-squared tests (Fishers Exact Test where appro-
priate) and analyses of variance (ANOVA), or in the
case of non-normal distribution of data, Mann–Whitney
U-tests, respectively, to detect differences (taken to be sig-
nificant at p ≤0.05) in outcomes between the subgroups.
No statistically significant differences were detected for
more than one sub-group for any outcome measure and,
as such, multivariable analysis was not performed. Unless
stated explicitly, significant differences between groups
were not detected for individual outcome measures. All
statistically significant results from univariate analysis are
reported with odds ratios (OR), and 95% confidence inter-
vals for sub-groups.
Ethical approval
Favourable ethical opinion was obtained from the University
Of Nottingham School Of Medicine Research Ethics Com-
mittee (L06062013 CHS EPH) and NHS research govern-
ance approval was granted by the Trust.
Results
Participant characteristics
The questionnaire was mailed to all 120 clinicians work-
ing in the specialist CAMHS, and after one follow-up
mailshot, the response rate was 50% (n = 60). The survey
was returned by 48 (47.5% response rate) non-medical
staff and 12 (63.2%) medical staff. Of the 97 clinicians work-
ing in community based roles, 52 (53.6%) responded to
the survey; of the 23 clinicians in ward based roles, 8
(34.8%) completed surveys were received. The predom-
inance of female respondents (66.7%) reflects the fact
that female clinicians comprised 77.5% (n = 93) of the
overall sample. The median age range of respondents
was 45–49 years. and four respondents (6.7%), all
nurses, identified themselves as current smokers. Less
than half (41.7%) of all respondents reported completing
a Trust provided e-learning training module in relation
to smoking. Differences in responses were not associated
with gender, age range, or smoking status. Further
demographic information relating to study participants
can be found in Table 1.
Clinician knowledge
Overall, respondents believed that 30% (SD 17.1) of the
general UK adult population, and 70% (SD 12.1) of the
population of adults with mental disorders smoked and
over three-quarters (79.6%) of participants knew that
Table 1 Characteristics of survey respondents








Occupational therapists 2 (3.3)
Psychologists 6 (10.0)
Systemic therapists 5 (8.3)
Other therapist 9 (15.0)
Other health professional 6 (10.0)
Medical staff Consultant 9 (15.0)
Junior doctor 3 (5.0)
Adolescent in-patient 5 (8.3)
T3 Community CAMHS 26 (52.0)
Self-harm team 3 (5.0)
Paediatric Liaison team 3 (5.0)
Early intervention psychosis
and substance misuse team
5 (8.3)









Current smoker 4 (6.7)
Ex-smoker 17 (28.3)




No Training 35 (58.3)
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an aid for patients who wanted to reduce their tobacco
consumption, but who did not want to quit.The interplay between tobacco smoke and mental
disorder
Less than half (40%; n = 24) of respondents were aware
that patients who smoke heavily can require higher
doses of psychotropic medication, whereas medical staff
were significantly more aware of this fact than their non-
medically trained colleagues [91.6% vs 27.1% (OR= 3.4;
95% CI 2.1-5.5); p < .001]. Again, less than half (40.%) of
all respondents were aware that serum levels of certain
psychotropic medications can rise if patients stop smok-
ing, and medical staff were significantly more likely to be
aware of this metabolic link than non-medical staff [83.3%
vs 29.1% (OR = 2.4; 95% CI 2.1-2.6); p < .001]. Further de-
tails concerning clinicians’ awareness of tobacco depend-
ence and its treatment in the context of mental disorders
can be found in Table 2.Carcinogenic properties
The great majority (88.3%) of respondents were aware that
“tar” is a carcinogenic component of tobacco smoke, while
over one third (38.3%) of clinicians believed that carbon
monoxide causes cancer and one-fifth (20%) of respon-
dents thought that nicotine is a carcinogen.
Symptoms of nicotine withdrawal
In relation to respondents’ awareness of the symptoms of
nicotine addiction, the median number of correctly identi-
fied symptoms was 7 from a possible 15 correct answers
(46.6%). Both incorrect and correct answers were aggre-
gated as described in methods, and a mean score of 5.8
(SD 2.3) out of a maximum of 15 was achieved overall.
Clinician attitudes and practice
Sixty percent of respondents felt that addressing tobacco
dependence among young people with mental disorders
was important; staff provided an overall mean rating of
6.27 (SD 2.1) and less than half (48.3%) of the respon-
dents felt that addressing patients smoking was within
their remit of responsibility as a mental health profes-
sional. The vast majority of staff (86.7%; n = 52) did not
feel that addressing patients’ smoking would have an ad-
verse impact on the therapeutic relationship, or that
quitting smoking during treatment for their mental dis-
order would have a negative impact on their recovery
(81.4%; n = 48). Over half (53.3%) of all respondents felt
that smoking was an important coping mechanism for
patients, helping them to deal with their mental disorder
and those clinicians who reported attending smoking
cessation training were significantly more likely to agree
[80.0% vs 34.3% (OR = 2.1; 95% CI 1.4-3.5); p = .001].
Half (50.0%) of all respondents reported confidence in
their ability to support patients in a quit attempt effect-
ively, providing a mean confidence rating of 5.6 (SD 2.4)
out of a maximum of 10, with clinicians who had
attended smoking cessation training scoring themselves
significantly higher than those who had not (6.4 vs. 5.1;
p = .051).
Nearly two-thirds (62.7%) of respondents reported
regularly assessing patients’ smoking status within their
working practice; the non-medical group were more
likely to do so in comparison to the medical group. Over
one-third (36.8%) reported routinely asking patients
about their motivation to quit or reduce their smoking,
whereas those clinicians who reported attending training
were significantly more likely to do so than those who
had not [54.1% vs 24.2%; (OR = 2.3; 95% CI 1.1-5.1);
p = .028]. Less than one third (29.8%) of respondents re-
ported signposting or referring patients to the local “stop
smoking” service and medical staff were less likely to
refer or signpost patients, in contrast to their non-
medical colleagues. Again, smoking cessation training
Table 2 Correct responses assessing clinician knowledge of tobacco dependence, its treatment, and its relation to
mental illness
Statement All respondents Medical staff
[n = 12; (%)]
Non-medical
staff [n = 48; (%)]
Sig [F, p]
Nicotine Replacement Therapy can interfere with psychotropic
medication (false)
23 6 (50.0) 17 (35.4) F = 2.25, p = .139
Addiction to NRT is common (false) 26 7 (58.3) 19 (39.5) F = .038, p = .846
Patients who smoke require higher doses of certain psychotropic
medication (true)
24 11 (91.6) 13 (27.1) F = 22.59, p<.001*
If patients stop smoking serum levels of psychotropic medication
can rise (true)
24 10 (83.3) 14 (29.1) F = 12.71, p = .001*
NRT can be used as an aid for smokers who want to reduce their
tobacco consumption (true)
47 10 (83.3) 37 (77.1) F = .886, p = .351
The recording of patients smoking status is mandatory (true) 55 10 (83.3) 45 (93.7) F = 1.57 , p = .217
*Denotes statistical significance at p < = 0.05.
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or signposting motivated patients to the local stop smok-
ing service compared to non-attendance [50.0% vs
15.1%; (OR = 1.4, 95% CI 1.1-1.8); p = .008]. Less than
one-quarter (22.4%) of respondents reported nicotine re-
placement therapy and behavioural support to be readily
available in their clinical setting, whereas those respon-
dents working in ward environments were significantly
more likely to report the availability of cessation support
than clinicians based in the community [62.5% vs 16.0%;
(OR = 3.9; 95% CI 1.7-8.9); p = .010]. Nearly all clinicians
(91.6%) were aware that the recording of smoking status
in electronic patient records was mandatory practice in
the Trust. Table 3 provides further details of the associ-
ation between training and respondents’ attitudes and
clinical practice.
Discussion
This study reveals gaps in overall knowledge with regard
to tobacco dependence, its treatment, and its relationTable 3 The influence of training on clinical practice and attit
young people with mental illness
Agreement (strongly agree/agree) (%)
Statement All responden
I feel it lies within the remit of my responsibility as a
mental health professional to address patients smoking
51.6
I routinely assess patients smoking status 62.7
I routinely ask patients about their motivation to quit smoking 36.8
I routinely signpost/refer patients to local stop smoking services 29.8
Access to stop smoking medication and support are readily
available in my clinic/on my ward
22.4
Smoking is an important coping mechanism for patients. 53.3
Patients stopping smoking while on my ward/in my clinic
would not interfere with recovery
81.3
Addressing patients smoking would not have an adverse
effect on the therapeutic relationship
86.6
*Denotes statistical significance at p=<0.05.with mental disorder among clinicians working within
specialist child and adolescent mental health services in
England. Due to the overall adequate response rate to
the survey of 50%, the inclusion of all clinical profes-
sions, the focus on both community and in-patient ser-
vices, and the size of the Trust, the results are likely to
be applicable to other CAMHS in England, However,
despite this, a number of study limitations are noted.
Generalizability may be limited by survey-typical selec-
tion bias and reporting bias, which may be reflected in
the circumstance that self-reported smoking status
among the respondents was noticeably lower (6.7%) than
the national average (21%) of smoking prevalence among
the UK adult population, and also lower than the rates
described in similar studies of mental health professionals
[15,20]. This, in combination with an overall small sample
size, meant that certain subgroup analyses were only mean-
ingful in parts and may be one reason why, in contrast to
previous research among adult mental health clinicians
[15,17,18], our results failed to highlight many differencesudes relating to addressing tobacco dependence among
ts Training attended Training not attended Sig (2-sided) [X2, p =]
64.0 48.8 X2 = 2.61, p = .088
62.5 62.8 X2 = .001, p = .595
54.1 24.2 X2 = 5.34, p = .028*
50.0 15.1 X2 = 8.06, p = .008*
16.6 26.4 X2 = .778, p = .526
80.0 34.3 X2 = 12.24, p = .001*
75.0 85.7 X2 = 1.08, p = .328
88.0 85.7 X2 = .066, p = 1.00
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ploration of differences according to smoking status. Yet, to
the best of our knowledge, this is the first study that ex-
plores smoking related knowledge and practice in child and
adolescent mental health specialist settings and thus makes
an important contribution to the literature.
Whilst a greater proportion of staff than previously
shown in a sample of adult mental health clinicians [15]
agreed that addressing tobacco dependence was important,
the rating of importance was moderate. The majority of
respondents felt that it was not within their remit of re-
sponsibility as a mental health professional, indicating that
staff attitudes remain overall ambivalent as shown previ-
ously [15,17,18]. A perceived divide in responsibilities be-
tween physical and mental health care, despite moves
towards a more holistic approach to patient care [14], ap-
pears to persist. Levels of confidence in effectively sup-
porting patient in a quit attempt were generally found to
be low. However, attending training appeared to be associ-
ated with improved practice in terms of asking patients
about their motivation to quit, and signposting or refer-
ring them for specialist smoking cessation treatment.
Like previous research [15,20] among adult mental health
clinicians illustrating prevailing misattributions regarding
smoking and mental illness (for example the perception of
the importance of tobacco for self-medication), this study
found that over half of respondents considered smoking an
important coping mechanism for patients in dealing with
their mental disorder. This suggests that there is a lack of
awareness relating to the importance of smoking cessation
for people with mental disorder [19], which may contribute
to reluctance among staff to address tobacco dependence
with their patients. However, despite this, the great majority
of staff did not believe that patients stopping smoking while
being treated for a mental disorder would have an adverse
effect on the therapeutic relationship or that it would inter-
fere with recovery, which should be viewed as positive sig-
nals in the light of the historic smoking culture in mental
health settings [4,16].
Accurate knowledge is essential if clinicians are to pro-
vide patients with appropriate advice and support in re-
lation to smoking and smoking cessation. In this survey,
gaps in knowledge in relation to smoking, smoking ces-
sation, and nicotine withdrawal were apparent across all
staff groups, indicating that clinician capacity to address
tobacco dependence among young people is likely to be
limited. Importantly, a lack of knowledge and awareness
in relation to the metabolic interactions between compo-
nents of tobacco smoke and antipsychotic medication is of
particular importance from a clinical perspective, in case
patients quit (or take up) smoking [3]. While the majority
of psychiatrists were informed of the issue (which demon-
strates a notable improvement to the earlier survey con-
ducted in adult mental health settings [15] other clinicalgroups were not, indicating a need for training across all
groups. This consideration is supported by the circum-
stance that reported training attendance, despite being low
at around 50%, was associated with more accurate know-
ledge and more frequent signposting and referrals to spe-
cialist smoking cessation support. CAMHS nurses and
other non-medical clinicians, particularly those working in
the community, are likely to have a greater number of
contacts with young patients and are thus perhaps more
likely to identify, advice, and provide support for young
smokers than psychiatrists. A lack of awareness and erro-
neous beliefs concerning smoking and smoking cessation
may reduce their motivation to address tobacco depend-
ence within this population, thus missing important op-
portunities for health promotion.
If tobacco dependence among young people with mental
disorders is to be addressed, then the effective identifica-
tion and support of young smokers is essential. Commis-
sioning strategies within this and many English mental
health Trusts have gone some way towards ensuring that
young smokers accessing specialist CAMHS are identified.
However, few clinicians appear to follow inquiries about
smoking status with an assessment of the young person’s
motivation to quit and their interest in receiving support,
and fewer still reported routinely signposting or referring
patients to local stop smoking services. This in combin-
ation with the lack of confidence reported by clinicians to
provide support to smokers, means that opportunities for
intervention are currently being missed. The accessibility
of NRT and cessation support is influenced by current
commissioning strategies. Within the Trust studied, and
possibly in other Trusts in England, only in-patient ser-
vices are incentivised to provide NRT and associated sup-
port, while community teams tend to refer or signpost
patients to local smoking cessation services. This practice
is exemplified by our finding relating to the reported ac-
cessibility of NRT in the respective clinical settings. The
effects of this practice on young people accessing commu-
nity teams may have consequences in terms of successful
cessation attempts. A delay in providing patients with ces-
sation support could result in a loss of motivation and rep-
resents a missed opportunity to improve physical and
mental health and could undermine effort to improve
health inequality.
Conclusions
To the best of our knowledge, this is the first study to as-
sess clinicians’ knowledge, practices, and attitudes relating
to smoking, smoking cessation and its relation to child and
adolescent mental health services. Our findings highlight
the need to increase the capacity of mental health profes-
sionals to address tobacco dependence within the context
of the treatment of mental disorders among young people.
Opportunities for smoke-free promotion and smoking
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strategies should incentivise all child and adolescent mental
health services to identify, advise and effectively support
(including the prescribing of NRT) young smokers. For
this to be successful, staff require comprehensive develop-
ment to improve knowledge and attitudes, and support for
clinicians is required to ensure that interventions to sup-
port smoking cessation within CAMHS do not negatively
impact on existing clinical priorities. Further research is re-
quired to assess the feasibility and effectiveness of interven-
tions targeted at addressing smoking among young people
with significant mental disorders.
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